Follow the DeltaーFly Pharma株式会社 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares trade on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, DeltaーFly Pharma株式会社 has published 50 reports. Market capitalisation: €1.5bn. The latest transaction was filed on 31 July 2026 (Holding update). Among the most active insiders: Macquarie Bank Limited. All data is openly available.
50
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Delta-Fly Pharma is a company operating in the health and pharmaceutical sector, listed on the XTKS market. It focuses on developing innovative treatments and therapeutic solutions.